Press Releases

 Filter by Provider

MarineMax, Inc. (NYSE: HZO), the world’s largest recreational boat and yacht retailer, marina operator and superyacht services company, plans to release its second quarter fiscal 2026 financial results before the opening of the New York Stock Exchange on Thursday, April 23, 2026. At 10:00 a.m. ET that day, the Company will conduct a conference call hosted by Brett McGill, Chief Executive Officer and President, and Mike McLamb, Executive Vice President, Chief Financial Officer and Secretary.

Union Pacific Corporation (NYSE: UNP) will release first quarter 2026 financial and operating results on Thursday, April 23, 2026, at 7:45 a.m. ET. The company’s management team will host a conference call and live webcast at 8:45 a.m. ET.

Empower, a leading workplace solutions provider and wealth manager, announced today it would be supporting Miles for Military (MFM), a nonprofit organization committed to supporting the comprehensive well-being of service members by providing flights home for active-duty junior enlisted personnel for holidays and other important events.

Takara Bio USA, Inc. (“Takara Bio USA”), a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced the launch of the Takara Bio Certified Service Provider (CSP) Program, which equips service providers to conduct customer experiments using advanced NGS and single-cell technologies from Takara Bio such as the Shasta® Single Cell System, a high-throughput single-cell analysis platform. Admera Health, a leading provider of NGS services, is recognized as the first organization to receive certification on the Shasta system, which positions Admera at the forefront of the single-cell genomics industry. With this program, Takara Bio USA is creating a network of trusted providers that have been trained and evaluated to deliver high-quality results, driving scientific progress globally.

Eligible Students Are Invited to Apply for a $2,500 Award to Support Their Studies

Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences:

Oatly Matcha, Oatly Organic Barista, and Oatly 4 Ingredient Launch Nationwide Throughout Canada

First-ever demonstration of an end-to-end quantum-classical workflow for simulating complex therapeutics, unlocking a credible path to near-term quantum advantage in health

AUSTIN, Texas, April 16, 2026 (GLOBE NEWSWIRE) -- Autonomize AI today announced Version 3 of its Autonomize Intelligence Platform, a complete foundation for building, deploying, and governing healthcare-native AI agents at enterprise scale. The release introduces deeper orchestration capabilities, 160+ Healthcare native AI Agents, over 50 pre-built system connectors, and a governance framework that enables organizations to activate AI within days.

CAMBRIDGE, Mass., April 16, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the appointment of Svetlana Makhni as Chief Financial Officer (CFO). Ms. Makhni will oversee Prime Medicine’s financial operations and strategy, including investor relations, financial planning and analysis, and corporate development.

FREIBURG, Germany and ROSCREA, Ireland, April 16, 2026 (GLOBE NEWSWIRE) -- Dr. Falk Pharma GmbH (“Dr. Falk Pharma”), a research-based pharmaceutical company specializing in digestive and metabolic medicine, and Renexxion Ireland Limited (“Renexxion”), a clinical-stage biopharmaceutical company, today announced that data from the Global Phase 2b MOVE-IT study of naronapride in 328 adults with moderate-to-severe idiopathic or diabetic gastroparesis has been selected for a late-breaking oral presentation at DDW 2026 in Chicago, USA, May 2-5.

THOMASVILLE, Ga., April 16, 2026 (GLOBE NEWSWIRE) -- Thomasville Bancshares, Inc. (OTCID: THVB), the parent company of Thomasville National Bank and TNB Financial Services, reported its financial results for the first quarter ended March 31, 2026. The company also announced its Board of Directors approved a cash dividend of $1.50 per share. The dividend will be paid on July 2, 2026, to shareholders of record as of June 12, 2026. In addition, the company announced its board of directors has authorized the company to repurchase up to $5 million of its outstanding common stock.

Deployments span leading provider organizations nationwide, including Mount Sinai Health System, Houston Methodist, and CommonSpirit Health

Recognition Highlights Leadership in Clean Energy Solutions for Material Handling Industry

Successfully completed the Company's initial public offering and listing on Nasdaq Capital Market in the first quarter of 2026

BOCA RATON, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage biotechnology company focused on developing therapies that harness the patient’s innate immune system, today announces new preclinical data for INB03 (XPro1595 for oncology).  The data will be presented at the American Association for Cancer Research (AACR) Annual Meeting 2026 in San Diego on April 17-22.

MANCHESTER, N.H., April 16, 2026 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (Nasdaq: ALGM) today announced it plans to release financial results for its fourth quarter and fiscal year 2026 prior to the market open on Thursday, May 7, 2026. Following the press release, Mike Doogue, President and Chief Executive Officer, and Derek D’Antilio, Executive Vice President and Chief Financial Officer, will host a conference call at 8:30 a.m. Eastern Time to discuss the Company’s results and business outlook.

Transformational AI Acquisition Accelerates Diginex’s Top Line with High Margin, High Growth Revenues via Expansion into AI Driven Customer Intelligence and Enterprise Agentic Solutions at Scale

ENGLEWOOD CLIFFS, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- Atlantic International Corp. (Nasdaq: ATLN), a global provider of outsourced services and workforce solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025.

LOS ANGELES, April 16, 2026 (GLOBE NEWSWIRE) -- Triller Group Inc. (Nasdaq: ILLR; ILLRW) ("Triller" or the "Company") today announced that the Company received formal notice from The Nasdaq Stock Market LLC (“Nasdaq”) that its common stock and warrants are once again available to trade on Nasdaq effective pre-market on Thursday, April 16, 2026.

BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced the appointment of Glenn Gormley, MD, PhD, as an independent director to its Board of Directors and co-chair of the Company’s newly established Science and Technology Committee of the Board of Directors.

Enterprise deployment supports healthcare security modernization while expanding Wrap’s addressable market into a high-growth sector

BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer, today announced that on April 15, 2026, Elicio granted an aggregate of 21,210 inducement stock options to a new employee, as an inducement material to such individual entering into employment with Elicio in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement stock options were approved by the Compensation Committee of Elicio’s Board of Directors and granted under the Elicio Therapeutics, Inc. 2024 Inducement Incentive Award Plan.

TURIN, Italy, April 16, 2026 (GLOBE NEWSWIRE) -- newcleo, in partnership with Politecnico di Torino, is proud to announce that they will host PHYSOR 2026, the world’s leading conference in reactor physics established by the American Nuclear Society (ANS). This marks the first time the prestigious event will be held in Italy, underscoring the country’s longstanding strength in academic research on nuclear energy as well as a renewed national interest in advancing nuclear technologies domestically.

Rogers has most coverage in Canada and U.S. with satellite-to-mobile

DALLAS, April 16, 2026 (GLOBE NEWSWIRE) -- Westwood Holdings Group, Inc. (NYSE:WHG) will release its first quarter 2026 earnings after the close of the New York Stock Exchange on Thursday, April 30, 2026. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central Time).

Transaction Delivers Fully Consolidated, Revenue-Generating, Aviation Business with Accelerating Growth

HERZLIYA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- Playtika Holding Corp. (NASDAQ: PLTK) announced today that it will release financial results for the first quarter of 2026 before U.S. markets open on Thursday, May 7, 2026.

ORLANDO, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NYSE: ABX), a leader in the alternative asset management industry, today announced it will release its first quarter 2026 financial results after the market closes on Thursday, May 7, 2026.

BRISBANE, Calif., April 16, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its first quarter 2026 financial results after the close of the U.S. markets on Thursday April 30, 2026. Following the release, the company will host a live conference call and webcast at 4:30 p.m. ET.

NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- Allied Gaming & Entertainment Inc. (NASDAQ: AGAE, “Allied” or the “Company”) today issued this supplemental update in light of the elevated trading volume in the Company’s common stock following its previously announced strategic transformation update. The Board of Directors is providing additional information regarding the Company’s shareholder value protection principles, the current status of certain strategic initiatives, and related market and execution risks. As previously disclosed, the Company’s strategic transformation remains focused on two principal areas: Digital Infrastructure and Token-Enabled Asset Platforms and AI-Driven Consumer and Token-Enabled Ecosystem.

Vancouver, BC, April 16, 2026 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSX-V: ROCK) (OTCQB: TRDTF) (“Trident” or the “Company” or the “Optionee”) is pleased to announce that it has signed a  Property Option Agreement dated April 15, 2026 (the “Agreement”) with North-Sask. Ventures Ltd. (“North-Sask.” or the “Optionor”) pursuant to which the Company has the right to acquire up to 100% interest in 19 individual mineral dispositions that total 3,586 hectares (ha) within the La Ronge Gold Belt.

SINGAPORE, April 16, 2026 (GLOBE NEWSWIRE) -- RECTITUDE HOLDINGS LTD (Nasdaq: RECT; the “Company” or “Rectitude”), a Singapore-based provider of safety equipment and related industrial products, today announced the evolution of its growth framework, officially renaming the "Central Business Platform" to the Rectitude Succession Bridge (“RSB”), designed to bridge the gap between legacy business owners and long-term industrial sustainability. This rebranding marks a significant milestone in the Company’s expansion strategy, underscored by the successful collaboration with INOS Pte. Ltd. (“INOS”) and G & L Hardware Marketing Pte. Ltd. (“G & L”) in the RSB ecosystem.

Partnership brings books to underserved children and families across New York City and Long Island, helping to build lifelong literacy habits

SAN DIEGO and TORONTO, April 16, 2026 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, today released its 2026 SMB Cyber Readiness Index – North America edition. This new report surveyed hundreds of small and medium-sized businesses (SMBs) from across the United States and Canada to uncover new insights into their cyber resilience, incidents and reporting, perceived threats, and investments – while analyzing the current appetite for managed services, cyber insurance and AI-powered applications.

Earn a 2026 EFJ Awards by submitting an application today!

BOSTON, April 16, 2026 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company developing next-generation cardiovascular therapeutics, and its clinical development division Sardocor, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to AAV-SERCA2a, an investigational gene therapy drug designed to treat cardiomyopathy associated with Duchenne muscular dystrophy (DMD-CM), building on prior human clinical experience with SERCA2a gene therapy and Medera’s ongoing clinical programs. AAV-SERCA2a is currently being evaluated in the first-in-human MUSIC-DMD clinical trial and aims to restore cardiac calcium handling by increasing expression of SERCA2a, a key regulator of heart muscle contraction and relaxation, using Medera's targeted intracoronary gene delivery approach designed to achieve therapeutic cardiac exposure at substantially lower vector doses than conventional systemic gene therapy approaches.

New partnership helps brands connect shopper-driven insights to product content execution, optimizing for conversion and visibility in AI-enhanced retailer search environments

New 2026 report finds weak visibility, slow substitute approvals, and manual exception workflows are eroding margin and continuity of care, while control towers, workflow orchestration, and connected supply chain IT emerge as the fix.

NOXX Cannabis, a leading recreational dispensary in East Peoria, is celebrating 4/20 with a full weekend of exclusive sweepstakes, deep discounts, and high-value doorbusters.

Students and teachers create presentations all the time. Class projects. Lesson plans. Group assignments. Final defenses.

You want your presentation to look professional. Static slides feel boring. Transitions and animations make ideas flow. They keep audiences engaged.

Business meetings need clear, professional slides. Bad design distracts. Good slides help close deals, align teams, and impress clients.

Acerand Therapeutics, a clinical-stage biotechnology company focused on developing innovative therapies in oncology, metabolic diseases, and immunology, today announced updated results from its first-in-human Phase I/II study ACE-106-001 (NCT06380660) evaluating ACE-106 (ACE-86225106) in patients with advanced solid tumors.

LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the pricing of an underwritten offering of 11,111,111 of its ordinary shares at an offering price of $9.00 per share. Gross proceeds to MeiraGTx from the offering are expected to be approximately $100 million, before deducting underwriting discounts and commissions and offering expenses. All of the ordinary shares in the offering are being sold by MeiraGTx.

In the modern software landscape, the trend toward ‘Software as a Service’ (SaaS) has become nearly universal. While monthly subscriptions offer some conveniences, they also introduce a recurring financial burden that many individuals and small businesses are eager to avoid. The desire for ‘digital sovereignty’, the ability to own and control your tools without a tether to a monthly billing cycle, is driving a massive return to standalone, free-to-use software. This is especially true for presentation tools, which are essential for everything from classroom projects to high-stakes boardroom pitches. Finding a high-quality, subscription-free alternative for your PC is not just about saving money; it is about ensuring that your productivity is never interrupted by a credit card expiration or an internet outage.